Lumito AB (publ) (NGM:LUMITO)
0.6590
-0.0030 (-0.45%)
At close: Jun 26, 2025
Lumito AB Company Description
Lumito AB (publ) engages in the medical research and development of imaging technology in Sweden.
It offers tissue analysis system based on upconverting nanoparticles, including SCIZYS system combining labeling and imaging technologies to locate and measure biomarkers in tissue samples.
The company’s technology addresses challenges in various application areas, such as drug development, academic research, and clinical diagnostics.
Lumito AB (publ) was incorporated in 2010 and is headquartered in Lund, Sweden.
Lumito AB (publ)
Country | Sweden |
Founded | 2010 |
Industry | Electromedical and Electrotherapeutic Apparatus |
Employees | 12 |
CEO | Sanna Wallenborg |
Contact Details
Address: Scheelevägen 19 Lund, 223 63 Sweden | |
Phone | 46 1 02 04 00 15 |
Website | lumito.se |
Stock Details
Ticker Symbol | LUMITO |
Exchange | Nordic Growth Market |
Fiscal Year | January - December |
Reporting Currency | SEK |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Sanna Wallenborg | Chief Executive Officer |
Henrik Ljung | Chief Financial Officer |